Paroxysmal Supraventricular Tachycardia
📧 Sign up to get email alerts when something new happens for Paroxysmal Supraventricular Tachycardia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-01-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Slate Run Pharmaceuticals, LLC)
FDA approved a supplemental application for a generic diltiazem hydrochloride product from Slate Run Pharmaceuticals, LLC under an ANDA.
-
FDA approval · 2025-11-14FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves the original application for diltiazem hydrochloride (Alembic Pharmaceuticals Limited), a generic product, for use in treating …
-
FDA approval · 2025-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Diltiazem Hydrochloride by Alembic Pharmaceuticals Inc. The action represents a supplemental reg…
-
FDA approval · 2025-07-10FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride (generic) from Sun Pharmaceutical Industries, Inc. under an ANDA. This a…
-
FDA approval · 2025-04-16FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-09-12FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for diltiazem hydrochloride by Mylan Pharmaceuticals Inc. under ANDA074910, indicating regulatory ap…
-
FDA approval · 2024-07-16FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for MATZIM LA (diltiazem hydrochloride) from Actavis Pharma, Inc.
-
FDA approval · 2024-07-03FDA Approved: ADENOSINE — Supplemental Application (Mylan Institutional LLC)
FDA has approved a supplemental application for adenosine (generic) from Mylan Institutional LLC, expanding access to the injectable drug.
-
FDA approval · 2024-04-23FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (FRESENIUS KABI USA, LLC)
FDA approved the original application for Verapamil hydrochloride as a generic drug, manufactured by Fresenius Kabi USA, LLC. Verapamil hydr…
-
FDA approval · 2022-09-23FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approves ScieGen's generic diltiazem hydrochloride under an Original Application (ANDA).
-
FDA approval · 2022-03-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original Abbreviated New Drug Application for verapamil hydrochloride from Heritage Pharmaceuticals (d/b/a Avet) as a gener…
-
FDA approval · 2020-06-25FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Propafenone hydrochloride as an Original Application (generic) for Upsher-Smith Laboratories, LLC.
-
FDA approval · 2020-04-29FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for diltiazem hydrochloride (generic) under ANDA074185.
-
FDA approval · 2020-03-27FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc., updating regulatory status for this …
-
FDA approval · 2020-03-25FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Caplin Steriles Limited)
FDA approves Caplin Steriles Limited's Verapamil Hydrochloride under an Original Application (ANDA). This confirms the availability of a gen…
-
FDA approval · 2019-11-14FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for propafenone hydrochloride from Rising Pharma Holdings, providing a generic version of the an…
-
FDA approval · 2019-10-31FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Propafenone Hydrochloride from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2019-10-30FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for propafenone hydrochloride, a generic antiarrhythmic drug. This approval s…
-
FDA approval · 2019-10-01FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
The FDA approved a supplemental application for Verapamil Hydrochloride by Teva Pharmaceuticals Inc., updating the drug’s labeling and appro…
-
FDA approval · 2019-09-25FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (generic) from Nivagen Pharmaceuticals, Inc., authorizing the sale o…
-
FDA approval · 2019-01-04FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Vitruvias Therapeutics)
FDA approved Propafenone hydrochloride as an Abbreviated New Drug Application (ANDA) for a generic antiarrhythmic, with Vitruvias Therapeuti…
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
The FDA approved the original application for Verapamil Hydrochloride by Somerset Therapeutics, LLC, enabling a generic version of verapamil…
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approves Somerset Therapeutics' Verapamil hydrochloride as an original application, granting a generic version of the drug.
-
FDA approval · 2018-04-16FDA Approved: ADENOSINE — Original Application (Fresenius Kabi USA, LLC)
FDA approves the original application for adenosine from Fresenius Kabi USA, LLC (generic adenosine) under ANDA205568.
-
FDA approval · 2018-02-16FDA Approved: ADENOSINE — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for Adenosine from Sagent Pharmaceuticals, establishing a generic intravenous form for treating paroxy…